Comparison of patient outcome according to renal replacement modality after renal allograft failure.

Chung, Byung Ha; Lee, Ja Young; Kang, Seok Hui; Sun, In O; Choi, Sun Ryoung; Park, Hoon Suk; Kim, Ji-Il; Moon, In Sung; Shin, Young Shin; Park, Joo Hyun; Park, Cheol Whee; Yang, Chul Woo; Kim, Yong-Soo; Choi, Bum Soon
Renal failure
2011NA ; 33 ( 3 ) :261-8.
ÀúÀÚ »ó¼¼Á¤º¸
Chung, Byung Ha -
Lee, Ja Young -
Kang, Seok Hui -
Sun, In O -
Choi, Sun Ryoung -
Park, Hoon Suk -
Kim, Ji-Il -
Moon, In Sung -
Shin, Young Shin -
Park, Joo Hyun -
Park, Cheol Whee -
Yang, Chul Woo -
Kim, Yong-Soo -
Choi, Bum Soon -
ABSTRACT
The aim of this study is to investigate the clinical course of patients with failed allograft according to the type of renal replacement modality. Three hundred sixty-eight patients with failed allograft were included. Of these, 233 patients started hemodialysis (HD-PSKT), 64 patients started peritoneal dialysis (PD-PSKT), and 71 patients underwent second transplantation (ReKT). At baseline, age, sex, laboratory findings, and comorbidity did not differ significantly among three groups. Chronic rejection was the most common cause of allograft failure (81.6%) followed by acute rejection (10.7%). During the observation period, 96 patients died. The most common cause of death was cardiovascular disease (39.6%) followed by infection (34.4%) and malignancy (8.3%). Infection was important cause of death within 10 years from allograft failure, but cardiovascular disease and malignancy occupied significant portion of death after 10 years from allograft failure. Significant difference was not found among the three groups in the cause of allograft failure and the cause of death. The patient outcome was better in the ReKT than in the other two groups and it did not differ significantly between the PD-PSKT and HD-PSKT. In multivariate analysis, old age, hypoalbuminemia, and high comorbidity were proved to be the independent risk factors for mortality and the ReKT was still significantly superior to the HD-PSKT and PD-PSKT after adjustment for other confounding factors. In conclusion, second transplantation may result in survival benefit, and proper management of nutrition and comorbidity may help to improve outcome in patients with failed allograft.
Hemodialysis, allograft failure, kidney transplantation, peritoneal dialysis
MESH
Adult, Cause of Death, Comorbidity, Female, Graft Rejection/mortality/*therapy, Humans, *Kidney Transplantation, Male, Middle Aged, Postoperative Complications/immunology/mortality/*therapy, *Renal Dialysis, Renal Insufficiency/immunology/mortality/*therapy, Republic of Korea/epidemiology, Treatment Failure
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
After allograft failure, 63.3% of the patients returned to HD, 17.4% returned to PD, and 19.3% underwent a second transplant; The most common cause of death was cardiovascular disease (39.6%) followed by infection (34.4%) and malignancy (8.3%). Infection was important cause of death within 10 years from allograft failure, but cardiovascular disease and malignancy occupied significant portion of death after 10 years from allograft failure.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.3109/0886022X.2011.559678
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå